The Affordable Medicines Facility—malaria: killing it slowly
暂无分享,去创建一个
K. Arrow | D. Jamison | R. Peto | A. Mills | P. Danzon | N. White | R. Laxminarayan | G. Mwabu | H. Gelband | C. Panosian
[1] D. Ansong,et al. Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data , 2012, The Lancet.
[2] G. Yamey,et al. Piloting the Affordable Medicines Facility-malaria: what will success look like? , 2012, Bulletin of the World Health Organization.
[3] F. Nosten,et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study , 2012, The Lancet.
[4] D. Mtasiwa,et al. Time To Move from Presumptive Malaria Treatment to Laboratory-Confirmed Diagnosis and Treatment in African Children with Fever , 2009, PLoS medicine.
[5] Kenneth J. Arrow,et al. Saving lives, buying time : economics of malaria drugs in an age of resistance , 2004 .
[6] J. Trape. The public health impact of chloroquine resistance in Africa. , 2001, The American journal of tropical medicine and hygiene.